University of Bath found that new psychoactive substance Bromazolam detections in deaths rose from 28 deaths in 2021 to 160 deaths in 2023, that Bromazolam was implicated in causing death in 82.8% of cases, with a median post-mortem blood concentration of 43 ng/mL – and was was co-detected with an average of 7 other substances per case.


